Cognizant (CTSH) Price & Analysis
CTSH Stock Chart & Stats
- Day’s Range
- MXN 1,184.40 - MXN 1,280.00
- 52-Week Range
- MXN 2.71 - MXN 1,531.00
- Previous Close
- MXN 1,280.00
- Volume
- 0
- Average Volume (3M)
- 28
- Market Cap
- MXN 546.79B
- Enterprise Value
- MXN 26.43B
- Total Cash (Recent Filing)
- MXN 1.55B
- Total Debt (Recent Filing)
- MXN 2.13B
- Price to Earnings (P/E)
- 11.9
- Beta
- 0.57
- Next Earnings
- Feb 10, 2027
- EPS Estimate
- 28.33
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.75%
Bulls Say, Bears Say
Bulls Say
AI Capabilities And Adoption
Broad AI deployment across delivery and a substantial engagement base strengthen Cognizant’s ability to capture enterprise modernization demand. Its trained workforce, expanding certifications, and AI platforms can improve productivity while creating differentiated, repeatable services for clients over the next several quarters.
Bookings And Financial-services Momentum
Bookings above revenue and a 1.3x book-to-bill indicate continued demand coverage, while double-digit Financial Services growth provides a strong vertical engine. The higher share of new and expansion bookings supports future revenue visibility and broadens the foundation for sustained growth.
Low Leverage And Solid Cash Generation
Very low leverage gives Cognizant financial flexibility to invest in AI, pursue targeted acquisitions, and return capital without relying heavily on debt. Meaningfully positive operating and free cash flow also support earnings quality and provide internal funding for strategic priorities.
Bears Say
Persistent Margin Compression
Although profitability remains solid, lower margins than in earlier periods suggest ongoing pricing, mix, or cost pressure within the services model. If this persists, revenue growth may translate less effectively into earnings and could constrain investment capacity or limit operating leverage.
Reduced Growth Outlook And Discretionary Pressure
The lower outlook signals that client budget caution is affecting near-term demand, particularly where spending is discretionary. Health care and consumer-facing exposure could make growth uneven over the next several quarters, reducing confidence in acceleration despite Cognizant’s strategic AI opportunities.
Uneven Cash Conversion And Working-capital Pressure
Positive cash generation remains substantial, but declining free cash flow and recurring operating-cash-flow coverage below net income indicate weaker conversion than earnings alone suggest. Higher receivables can absorb liquidity and make funding for investment, acquisitions, or shareholder returns less predictable.
CTSH FAQ
What was Cognizant’s price range in the past 12 months?
What is Cognizant’s market cap?
When is Cognizant’s upcoming earnings report date?
How were Cognizant’s earnings last quarter?
Is Cognizant overvalued?
Does Cognizant pay dividends?
What is Cognizant’s EPS estimate?
How many shares outstanding does Cognizant have?
What happened to Cognizant’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Cognizant?
What is the TipRanks Smart Score and how is it calculated?
Cognizant Stock Smart Score
Company Description
Cognizant
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
- Sector
- General
- Industry
- Information Technology Services
- CEO
- Ravi Kumar Singisetti
- Employees
- 356,700
- Website
- www.cognizant.com
- Address
- 300 Frank West Burr Boulevard, Teaneck, NJ, 07666, US
Cognizant (CTSH) Earnings & Revenues
CTSH Company Deck
CTSH Earnings Call
Earnings Call SentimentPositive
The call was broadly positive. Cognizant delivered solid revenue growth, its highest adjusted operating margin in four years, strong Financial Services momentum, improved bookings mix, rising AI adoption and robust cash generation. Management also highlighted significant investments in AI talent, platforms, partnerships and growth priorities. These strengths were partly offset by reduced full-year guidance, softer fourth-quarter expectations, discretionary spending pressure in health care and consumer-facing sectors, industry-specific challenges, and higher furlough and restructuring impacts.
View all MX:CTSH earnings summariesCTSH Net sales Breakdown
- 30.06% Health Sciences
- 29.15% Financial Services
- 24.23% Products and Resources
- 16.56% Communications, Media and Technology
CTSH Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 6 | 3 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 11 | 0 | 1 |